Cero Therapeutics Holdings CERO
OTC CERO
$0.00 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cero Therapeutics Holdings, Inc. (CERO) Non Operating Interest Expenses (2023 - 2026)

Updated

Cero Therapeutics Holdings (CERO) reported Non Operating Interest Expenses of $690,044 for Q2 2026, up 315.0% from the prior quarter.

Analysis

Cero Therapeutics Holdings, Inc. (CERO) Non Operating Interest Expenses (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cero Therapeutics Holdings' Non Operating Interest Expenses came in at $803,073; for FY2024, it came in at -$21,846.

  • By year, Non Operating Interest Expenses came in at -$138,340 in FY2023.
  • The Q2 2026 figure ranks as the highest quarterly Non Operating Interest Expenses in data going back to Q1 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 690,044.00
Mar 31, 2026 166,286.00
Dec 31, 2024 -48,839.00
Sep 30, 2024 -4,418.00
Jun 30, 2024 16,977.00
Mar 31, 2024 14,434.00
Dec 31, 2023 -20,089.00
Sep 30, 2023 -157.00
Jun 30, 2023 -59,417.00
Mar 31, 2023 -16.00
API Access

Cero Therapeutics Holdings, Inc. Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CERO&period=max&api_key=YOUR_API_KEY